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ABSTrACT
Introduction: Nepal cannot afford renal replacement therapy for End Stage Renal Disease due to lack 
of resources. Early diagnosis of Chronic Kidney Disease and its risk factors may reduce the need of 
renal replacement therapy.
Methods: A community-based screening on, 3218 people ≥20 years were assessed by door-to-door 
survey in Dharan, Nepal. Health status, lifestyle habit, physical examination and blood pressure 
were evaluated. Spot urine was examined for proteins and glucose by dipstick. Fasting blood glucose 
and serum creatinine were measured in a subset of 1000 people and the prevalence of Chronic Kidney 
Disease was evaluated.
results: Overweight, obesity, hypertension, diabetes and proteinuria were found in 20%, 5.0%, 
38.6%, 7.5%, and 5.1% respectively. In the subset group, Chronic Kidney Disease was detected 
in 10.6%. Multivariate analysis indicated age (P <0.0001) and diabetes (P = 0.027) as statistically 
significant predictors for Chronic Kidney Disease. Total of 848 patients entered the management 
program of lifestyle modification and pharmacologic intervention. Glycemic and blood pressure 
control was achieved in 60% and 72%, respectively. Regression or stabilization of proteinuria was 
reported in 52% of patients. 
Conclusions: Burden of Chronic Kidney Disease and cardiovascular risk factors are high in Dharan. 
Reasonable control of blood sugar, hypertension and proteinuria was achieved in this program. 
Findings indicate that activation a large prevention and intervention program to tackle Chronic 
Kidney Disease and Cardiovascular Disease in Nepal is needed.
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INTrODUCTION
Chronic kidney disease (CKD) is a worldwide public 
health problem. Nepal, one of the poorest countries in 
the world - at 138th position of human development 
index,1 has grossly limited treatment options for CKD. 
The cost per month treatment per patient for dialysis 
makes the RRT a rare choice for most of the ESRD 
patients. 
Till now kidney transplant is limited to two centers in 
the Capital city of Nepal. Thus, because of the cost 
and complexity of the treatment less than 5% of ESRD 
population receives any form of renal replacement 
therapy in the country, which undermines the need to 
establish programs to prevent renal disease progression. 
Before advocate for action, however, it would be useful 
to know the prevalence of CKD and its risk factors. 
In this scenario, a community-based screening in people 
≥20 years old was conducted in Dharan – a large town 
in eastern Nepal - with the aims to  assess the prevalence 
of risk factors for chronic kidney disease (hypertension, 
diabetes and obesity), to define the prevalence of CKD, 
and to characterize the overall cardiovascular disease 
risk in this population. This finding summaries result 
of the screening that was carried out sequentially in 
the initial four administrative wards of Dharan in overall 
3218 people.
METHODS
A survey is being conducted in the Dharan municipality. 
As a part of sequential survey this study was conducted 
in 4 VDS out of 19 VDCs in Dharan municipality, 
Dharan, Nepal from 2003 to 2005. Ethical approval 
wask taken from IRC-BPKIHS. 
A series of meetings were held in Dharan initially with 
local leaders, local Non-governmental organizations 
- to explain the initiative, procedures and possible 
benefits of screening and intervention program to the 
community in the long run. In the meantime, a series 
of articles were published in the local language national 
daily newspaper to create awareness among people. 
Furthermore, leaflets on prevention and treatment of 
kidney diseases were distributed and exhibited in public 
places. All these activities were also accompanied by 
meetings and interaction programs with the general 
population, including awareness parade in the city.
BP Koirala Institute of Health Sciences (BPKIHS) has 
planned and coordinated the program. The local NGOs 
were responsible for mobilisation of local volunteers, 
coordination with local leaders and the community 
participation. 
Survey teams have been organized and consist of a 
local leader, resident doctors, medical students and 
nurses. The local leader was the head of the ward, a 
member of the NGO’s. The entire team was trained on 
the methodology and the procedures prior to survey by 
coordinators of the project at BPKIHS and re-enforced 
from time to time. The medical students were chosen 
from the highest rank to lowest rank in a team (i.e. 
post graduate of medicine, third, fourth and final year 
of medical school). This strategic organisation has been 
established in order to sensitise medical students on 
preventive aspects of CKD and cardiovascular diseases. 
Each team had a team leader, which visited door-to-
door each household of the given area planned to be 
screened. 
The records of household numbers in the administrative 
ward one to four of Dharan were retrieved from the 
local administrative office. The four wards had 1927 
households with a population of 8585. The population 
≥20 years were 3312. A total of 94 persons were 
excluded from screening due to either acute illness or 
fever, pregnancy, not available in the household or not 
willing for screening. All the screening procedures were 
carried out within each household of individuals.
All subjects aged 20 years or older were considered 
eligible for the evaluation. On the day of screening a 
brief questionnaire that included demographic data, 
and information on smoking habit, and physical activity 
as well as personal and family history of diabetes, 
hypertension, cerebrovascular accident, heart attack or 
angina, and kidney disease was introduced to a given 
person in a family and filled by the team personnel. 
Thereafter height, weight and blood pressure were 
measured according to standard guidelines. 
Participants were then instructed to void a clean, 
mid-stream spot urine specimen in a vessel which 
was examined for protein and glucose. Random blood 
glucose measurement was also performed. In a subset of 
1000 people, fasting blood sugar and serum creatinine 
were also measured, at later stage when new resources 
became available. One thousand subjects were selected 
by means of a proportionate stratification, according to 
age and gender at the time of the screening. This sample 
was representative of the 3200 screened subjects 
because each category was adequately represented 
selecting a sample from each stratum separately and 
considering sample size proportional to the relative size 
of the strata. The screening visit was also used for 
the health education of the members of the family on 
kidney and cardiovascular diseases.
Blood pressure recording and hypertension was defined 
according to the guideline The JNC 7 Report.2 
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Body weight and height was assessed with all subjects 
standing without shoes and heavy outer garments to the 
nearest 0.1 kg and 1 cm, respectively, and body mass 
index estimated according to standard normograms. 
WHO criteria 1999 was used to define overweight and 
obesity.3 Proteinuria and glycosuria were measured by 
dipstick (Multistix, 10SG, Bayer Diagnostics Bridgend, 
UK). Subjects with positive proteinuria dipstick had a 
second confirmatory urinary dipstick evaluation 10 to 
15 days after the initial screening. Subjects who at 
screening had urinary tract infection, fever or menstrua-
tion (for women) were excluded from the evaluation to 
avoid the bias of transiently elevated proteinuria.
Plasma glucose concentration was determined by glu-
cose oxidase-peroxidase method (Vitalab Selectra-2, 
Merck, Germany). The diagnosis of diabetes was de-
fined as per ADA criteria.4 Individuals with self-reported 
prior physician-diagnosis of diabetes were classified as 
having previously diagnosed diabetes. 
In the subset of 1000 subjects who underwent esti-
mation of serum creatinine, Glomerular Filtration Rate 
(GFR) was also calculated using the abbreviated Modi-
fication of Diet in Renal Disease (MDRD) equation with 
four variables.5 CKD was defined according to the 
National Kidney Foundation Practice Guidelines,6 Five 
stages of CKD were classified.7 
In addition, the risk for cardiovascular disease was as-
sessed in the same subset of 1000 subjects by modi-
fication of previously published score system.8 To this 
purpose, for each subject, a cardiovascular risk score, 
0 to 6, was estimated by allocating the value of one 
to each of the following six features when present at 
screening: a) overweight (BMI >25 Kg/m2), b) hyper-
tension (SBP ≥140 or DBP ≥90 mmHg), c) fasting 
plasma glucose level >97.2 mg/dl) d) proteinuria (dip-
stick positive), e) smoking, f) serum creatinine (>1.5 
mg/dl). Since renal dysfunction is an independent risk 
factor for cardiovascular events (9) serum creatinine 
was also added in the proposed scoring system.
Chi-square test was used to compare prevalence of 
CKD and its risk factors by age classes (20-39 years, 
40-59 years, >60 years). A multiple logistic regression 
was implemented with the PROC LOGISTIC in SAS in 
order to identify putative risk factors associated with 
prevalence of CKD. 
To identify a minimal set of independent predictors all 
the covariates measured at screening were univariately 
evaluated in logistic regression models. All factors found 
significantly (P<0.05) associated with the dependent 
variable were included in the final model. Age, BMI, 
SBP, DBP were considered as continuous variables in 
the primary analysis and categorized in a secondary 
explorative analysis. 
The Hosmer-Lemeshow goodness-of-fit statistic was 
used to evaluate model fit. The data were entered 
with the use of Microsoft Excel and were exported and 
analyzed with the use of SAS software (version 9.1, 
SAS Institute, Inc., Cary, NC). The data were presented 
as number (percentage). Statistical significance was 
assessed at the 5% level of significance. All p values 
were two-sided.
rESULTS
A total of 3218 subjects were screened in the program, 
with slight female preponderance (52%) (Table 1). The 
mean age of the participants was 42.9±14.9 years. 
Housewife and shop-owner constituted the majority of 
the screened population. There were 19.7% farmers. 
The majority of screened subjects were either illiterate 
or educated up to secondary school (64.2%).
Table 1. Characteristics of the screened population.
Particulars Number (%)
Gender Male 1542 (47.9)
Female 1676 (52.1)
Occupation
Housewife 1132 (35.2)
Shop-owner 863 (26.8)
Farmers 634 (19.7)
Daily wage-earner 134 (4.2)
Other 455 (14.1)
Education
Illiterate 496 (15.4)
Secondary School 1569 (48.8)
High School 1153 (35.8)
Smoker 758 (23.7)
Sedentary habit 1705 (53)
Body Mass Index <18 630 (19.6)
18-25 1773 (55.1)
25.29 643 (20)
≥30 172 (5.3)
Hypertension 1243 (38.6)
Diabetes 242 (7.5)
Proteinuria 163 (5.1)
___________________________________________________
Most of the subjects (55%) had a normal BMI, while 
overweight accounted for 20% of the screened 
population. Obesity was found in 5% of the people 
(Table 1). Interestingly, underweight was documented 
in 20%. Overweight and obese were mostly women 
(33%). 
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Table 2. Prevalence of CKD and its risk factors by 
age.
Particulars Age (years) in percentage
20-39 40-59 ≥60 P value
CKD 3.4 11.4 30.5 <0.001
Proteinuria 2.2 6.1 11.1 <0.001
Hypertension 23.2 47.3 64.2 <0.001
Diabetes 2.5 9.3 18.9 <0.001
Obesity 3.8 7.3 5.4 <0.003
___________________________________________________
Table 3. Multiple logistic regression model to predict 
CKD.
risk Factors Odds ratio 95% CI* P value
Age 1.05 1.03, 1.06 <0.0001
Sex 1.5 0.95, 2.43 0.08
Education 0.98 0.94, 1.01 0.183
Smoking 0.83 0.49, 1.39 0.47
BMI 0.97 0.92, 1.02 0.226
SBP 1.01 0.99, 1.03 0.18
DBP 0.99 0.96, 1.01 0.36
Diabetes 2.44 1.11, 5.32 0.027
*two values are upper and lower limit of confidence 
interval
Hypertension was found in 38.6% (n=1243) of subjects 
(Table 1). The mean age of hypertensive was 49.2±14.3 
years. The proportion of the subjects with hypertension 
increased with age (Table 2). Hypertension was more 
common in obese (53.5%) than in non-obese (37.8%). 
47% of the hypertensive were newly detected during 
the screening. 51% of the known hypertensive were 
on treatment with blood pressure lowering medications 
and only 14% of them (n=135) had adequate blood 
pressure control according to JNC7 criteria.
Diabetes was found in 7.5% (n=242) of subjects. The 
mean age of all diabetics was 55.5±14.4 years, and 
44.2±11.2 years for the newly diagnosed subjects. 
The prevalence of diabetes increased with age (Table 
2). More diabetes was documented in overweight or 
obese than in underweight subjects. Less than half 
(n=114) of the previously diagnosed diabetic patients 
were on treatment and among them only 25% (n=28) 
had adequate control of their blood sugar level. 
Hypertension and diabetes in combination were found 
in 4.67% (n=150) of screened population. 
Proteinuria measured by dipstick of random voided urine 
sample was found in 5.1% (n=163) of the screened 
population. The distribution of proteinuria is depicted in 
Figure 1. Majority of them had 1+ proteinuria. Dipstick 
positive protein ≥3+ was recorded in 0.6% of the 
screened asymptomatic population. There is a trend 
for higher prevalence of proteinuria in underweight 
(6.0%) than in the overweight (5%) and obese (4%) 
subjects. Proteinuria was found in 7.9% of hypertensive 
population but only 3.3% in normotensive subjects. 
14.5% diabetics were proteinuric as compared to 4.2% 
of non-diabetics. There was linear relationship between 
age and proteinuria with prevalence of proteinuria 
5 times higher in subjects ≥60 years than in young 
people (≥20 - 39 years). Together proteinuria and 
diabetes were observed in 1.1% (n=35) of the screened 
population, whereas 0.8% (n=27) of subjects had 
combination of proteinuria, hypertension and diabetes.
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Figure 1. Distribution of dipstick positive proteinuria 
in the screened population (n=3218 subjects). 
In the subpopulation of 1000 subjects screened in the 
second phase of the program, serum creatinine ≥1.4 
mg/dL (normal: 0.6 – 1.3 mg/dL) was recorded in 1.4 
% (n=14). In CKD stage 0 eGFR (by MDRD formula) 
92.4±23.0 ml/min/1.73 m2. In stage 1, 2, and 3 
eGFR was 104.1±11.8, 78.4±9.1 and 52.0±7.0 
ml/min/1.73 m2, respectively.  In stage 4 eGFR was 
21.3±5.1 ml/min/1.73 m2 and in  stage 5 was 
12.0±1.5 ml/min/1.73 m2. Overall CKD was present in 
10.6% (n=106) and proteinuria in 5.2% (n=52). The 
distribution of proteinuria was 2.4% (n=24) in CKD 
stage 1, 2.0 (n=20) in CKD stage 2, 0.4% (n=4) in 
CKD stage 3 and 0.4% (n=4) in CKD stage 4.
According to MDRD equation, GFR ≤60 ml/min/1.73m2 
(stage 3-5) was found in 6.3% (n=63) of the subjects. 
85% of the CKD cases were detected during the 
screening. The mean age of CKD patients was 
52.1±14.2 years with prevalence of CKD increasing 
with age. In subjects with BMI below 18 eGFR was 
91.1±25.0 ml/min/1.73 m2.
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Multivariate logistic regression analysis of screened risk 
factors showed that age [OR 1.05 (1.03 to 1.06), p 
<0.0001] and presence of diabetes [OR 2.44 (1.11 to 
5.32, p=0.027)] were the only statistically significant 
predictors for CKD (Table 3). 
The frequency distribution of Cardiovascular Disease 
(CVD) risk score in the subgroup of screened subjects 
showed that 78% of the screened population had at 
least one risk factor for CVD. CVD risk score ≥ 2 or 
more was present in 47.3% (n=472) of subjects.
Eight hundred and forty eight subjects screened 
positive for hypertension, diabetes, proteinuria and 
CKD entered the intervention phase of the program. 
The patients were followed up in ‘Renal Disease 
Prevention Clinic’ at B P Koirala Institute of Health 
Sciences. They were counseled for healthy lifestyles, 
which include moderation of alcohol consumption, 
cessation of smoking, increase in physical activity, 
reduction of dietary sodium/salt, weight reduction in 
those individuals who are overweight or obese, and 
prescribed cheap available medicine for their ailment. 
15% drop out during follow-up within one year. After 
1 year of management, blood pressure reduction to 
<140/90 mmHg in hypertensive patients was achieved 
in 72% (i.e. from 141.8±21.3 mmHg to 129.9±18.6 
mmHg, P<0.0001 for systolic blood pressure; and from 
91.7±11.9 mmHg to 83.6±10.6 mmHg, P<0.0001 
for diastolic blood pressure). 
Similarly, glycemic control (fasting glucose <120 mg/
dL and/or HbA1c ≤7%) was reached in 60% of diabetic 
patients. Blood glucose lowered from 127.7±60.5 mg/
dl to 113.2±62.4 mg/dl (P<0.0001).
Regression or stabilization of proteinuria was reported 
in 52% of patients.  In the 74 subjects with Dipstix 
positive (i.e. ≥1+) the proteinuria lowered from 0.94 
g/24h (0.68 to 1.70 g/24h) to 0.30 g/24h (0.14 to 
1.30 g/24h) (P=0.19). Before intervention 1.4% (n=1) 
of subjects was in CKD stage 0, 48.7% (n=36) in CKD 
stage 1, 39.2% (n=29) in CKD stage 2, 5.4% (n=4) 
in stage 3, and 5.4% (n=4) in stage 4. At the end of 
the follow-up on treatment, 41.9% (n=31) of subjects 
was in CKD stage 0, 29.7% (n=22) in CKD stage 1, 
16.2% (n=12) in CKD stage 2, 8.1% (n=6) in stage 3, 
and 2.7% (n=2) in stage 4, and 1.4% (n=1) in stage 
5. Five patients died including 2 patients on RRT.
DISCUSSION
This is the first community-based screening and 
intervention study in Nepal with the aim to detect and 
manage risk factors for chronic kidney disease and 
cardiovascular disease, which ultimately would prevent 
renal disease progression and Cardiovascular deaths. 
According to this screening, one fourth of the subjects 
were ≥20 years were either overweight or obese. 
Interestingly, underweight was also documented in a 
significant percentage of the screened subjects (20%). 
Typically, there were more female in the overweight 
and obese group than male counterpart, as documented 
elsewhere.10 Recent rapid urbanization of Dharan, 
making energy dense food available in the city for 
relatively rich people may be associated with weight 
gain. On the other hand, those who migrated from rural 
areas to city and remained relatively poor might have 
to depend on low quality of food, therefore, at risk to 
become underweight. However, to closely define this 
relationship, family income and food habit should have 
been evaluated.
Hypertension was present in one third of the screened 
subjects, of which only 50% were previously known 
to have high blood pressure. This high prevalence of 
hypertension is in line with early findings in selective 
Nepalese population such as Sherpa11 and Tibetans.11,12 
Results from studies in Nepalese population suggest 
that not only age (as we found), the body fat and salt 
intake, but also intake of potassium, magnesium and 
calcium contribute to the genesis of hypertension in 
Nepalese inhabitants.6
Similarly, a high prevalence of diabetes (7.5%) was 
observed in the present screening program, although 
markedly lower than previously reported (14.6%) in 
Nepal.13 These numbers, however, contrast sharply 
with the projected estimate by WHO of 4% of diabetes 
in Nepal for 2030.14 The high prevalence of diabetes in 
Nepal might just reflect better screening strategies than 
those adopted in the past. To this, however, it should 
be certainly added the influence of lifestyle changes 
associated with socioeconomic development and 
urbanization.15 Indeed, together the influence of crucial 
events in the past three to five decades might have 
resulted in the current high prevalence of hypertension 
and diabetes. Migration of population from hilly to plain 
areas leading to gross reduction in physical activities,11 
consumption of locally made high salt containing junk 
foods, rapid urbanization, increased in body fat due 
to consumption of westernized diet of poor quality,15 
maternal malnutrition leading to low birth weight,10 lack 
of awareness on prevention of diseases might be some 
of the contributors. 
Screening for CKD has relied on the detection of 
albuminuria or proteinuria in urine samples.7 Dipstick 
protein on spot urine samples analysis has imperfect 
accuracy in the diagnosis of persistent proteinuria, but it 
is an inexpensive and simple test that can be performed 
in mass screening of apparently healthy subjects,16 
particularly in low-resource environment. It has also 
been reported to predict progression of CKD to ESRD.17 
Sanjib  et al. Community-Based Screening for Chronic Kidney Disease, Hypertension and Diabetes in Dharan
JNMA I VOL 52 I NO. 5 I ISSUE 189 I JAN-MAR, 2013210
Using the dipstick test, here we found that in the Dharan 
community screening the prevalence of proteinuria was 
5%, comparable to values (4.4%) reported in a close 
region in an Indian survey in Delhi,18 but higher than 
the more westernized worksite screening in Singapore 
(1.1%),19 the general population screening in Hong Kong 
(3.2%),20 or the Ausdiab screening in Australia (2.4%).21 
It was similar to that of Okinawa general population 
survey (5.3%) in Japan in more than 100,000 people.17 
The difference in the prevalence of proteinuria may be 
due to different ethnicity of screened populations, age 
or selection of the screened cohort.  When resources 
became available, serum creatinine was also measured 
in a subset of 1000 subjects among the full cohort 
screened previously for proteinuria. Based on the NKF 
definition of CKD7- where albuminuria was substituted 
by dipstick proteinuria (score ≥1+) - the prevalence of 
CKD in the Nepalese population was 10.6%, similar to 
that reported in the ≥ 40 years people of Beijing China 
(11.3%),22 and in the developed countries, namely 
USA (NHANES III: 11%),23 and Australia (AusDiab: 
14%)21 that also used proteinuria as screening test. 
Since albuminuria is an earlier, more sensitive index of 
CKD than proteinuria,24 it could be reasonably expected 
that the prevalence of CKD documented in the Dharan 
population was actually underestimated. So far, 
however there has been no attempt to relate risk factors 
to the development of CKD in Nepal. Age, hypertension, 
diabetes, dyslipidemia, smoking, and non-Caucasian 
ethnicity have been recognized as risk factors for CKD 
worldwide.16,17,19,25-27 By multiple logistic regression 
analysis, we found that, beside age, only diabetes was 
statistically significant predictor of CKD. These findings 
further underline the need to screen people at least for 
diabetes in the Nepalese community in order to prevent 
as much as possible the renal and CV complications. 
Indeed, evidence is available that primary prevention 
of diabetic nephropathies in hypertensive,28,29 and 
normotensive patients,30 with diabetes is feasible with 
cheap angiotensin converting enzyme inhibitors.
There is no particular benefit from the screening 
if subjects, positive at the survey for the major 
parameters could not enter an intervention phase 
of the program. After one year follow-up - based on 
low cost antihypertensive, antiproteinuric (mainly 
ACE inhibitors) or oral antidiabetic drugs - 60 to 70% 
patients entered the intervention phase had good 
blood pressure or glycemic control, while stabilization 
or regression of proteinuria was achieved in 50% of 
the cases. Moreover, even patients already known to 
be hypertensive or diabetic, but with poor compliance 
to therapy or not on treatment before screening, did 
benefit from participating to the management phase of 
this program. Evidence is available that complications 
related to hypertension and/or diabetes can be largely 
preventable. In diabetic patients, 10 mmHg reduction 
of blood pressure values lowers micro-vascular 
complications up to 37%,31 as well as one percent 
lowering of glycosylated hemoglobin results in 16% 
reduction in myocardial infarction.32 The initial findings 
of the Nepal intervention program showing better 
blood pressure and glycemic control than in the past 
provides hope for long-term significant benefit on renal 
and cardiovascular outcomes. Moreover these results 
indicate that pharmacological interventions, recently 
shown to slow the burden of ESRD in developed 
countries,33,34 could be effective in providing reno- 
and cardiovascular protection also in the low-resource 
setting of the emerging world, proving that a proper 
organization is set up. There are certain shortcomings 
in the Dharan screening. Hematuria and leukocyturia, 
that might have affected proteinuria results, was not 
routinely evaluated. However, all subjects with fever or 
symptomatic urinary tract infection were excluded from 
the proteinuria screening. Moreover, the prevalence of 
CKD was estimated using MDRD prediction equation of 
GFR, not validated in the Nepalese population. 
Large-scale screening and management program 
in resource poor setting should be mandatory. In a 
developing country, like Nepal, people do not seek 
regularly medical advice due to lack of awareness of 
disease, belief of ‘apparently healthy’ in the absence 
of symptoms of chronic diseases, and, not last, lost of 
day-wage. This would result in too late referral, if any, 
to the medical unit or, more commonly, death without 
known reasons. The involvement of local community 
people and leaders along with large and sustained 
educational programs for people and healthcare 
workers and development of an organizational network 
of doctors, medical students, nurses and volunteers 
under an academic coordinating center, as we did in 
Nepal, is a requirement to assure smooth and reliable 
screenings and, far more important, to use at best the 
limited resources and interventions for effective care of 
patients and management of amenable risk factors for 
CKD and CVD. This more concerted and multi-sectorial 
approach is essential to help reverse the negative trend 
in the incidence of these chronic diseases in emerging 
countries and overcome the cost and complexity of 
renal replacement therapy out of reach for these low-
income environments. 
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